GO Term |
---|
extracellular region |
plasma membrane |
membrane |
external side of plasma membrane |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
100 | N-linked (GlcNAc...) asparagine |
|
||
193 | N-linked (GlcNAc...) asparagine | |||
233 | N-linked (GlcNAc...) asparagine |
|
||
249 | N-linked (GlcNAc...) asparagine |
|
||
263 | N-linked (GlcNAc...) asparagine |
|
||
297 | N-linked (GlcNAc...) asparagine |
|
Pathway Name | Organism |
---|---|
Interleukin-1 signaling | Homo sapiens |
Interleukin-10 signaling | Homo sapiens |
Potential therapeutics for SARS | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110750 | type 1 diabetes mellitus 11 | |
DOID:0110751 | type 1 diabetes mellitus 12 | |
DOID:0110752 | type 1 diabetes mellitus 13 | |
DOID:0110753 | type 1 diabetes mellitus 15 | |
DOID:0110754 | type 1 diabetes mellitus 17 | |
DOID:0110755 | type 1 diabetes mellitus 18 | |
DOID:0110756 | type 1 diabetes mellitus 19 | |
DOID:0110757 | type 1 diabetes mellitus 20 | |
DOID:0110758 | type 1 diabetes mellitus 21 | |
DOID:0110759 | type 1 diabetes mellitus 22 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024